Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Heather Woolery Lloyd

Dermatology Miami, FL Medical Doctor

NPI 1225092539 CMS profile 10131

1475 Nw 12Th Ave, Box016960, Miami, FL 33136

Open in the dashboard

General payments

$609,238

507 records reported · program years 2019–2025

Research payments

$44,121

Paid to them · 16 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$381,223 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Heather Woolery Lloyd of Miami, FL is reported in the CMS Open Payments database as having received $609,238 across 507 general payments and $44,121 in research payments paid to them. Separately, studies naming them as principal investigator received $381,223 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $114,598 97
2024 General $171,682 84
2024 Research $1,331 4
2023 General $94,640 94
2023 Research $1,861 1
2022 General $139,330 133
2021 General $35,839 34
2020 General $21,361 9
2020 Research $40,928 11
2019 General $31,788 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Heather Woolery Lloyd
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Heather Woolery Lloyd were reported at $114,598. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Heather Woolery Lloyd Dermatology median Middle half National median
2019 $31,788 $454 $129–$1,240 $163
2020 $21,361 $235 $81–$756 $114
2021 $35,839 $377 $108–$1,108 $132
2022 $139,330 $514 $143–$1,391 $149
2023 $94,640 $607 $159–$1,674 $160
2024 $171,682 $751 $204–$1,903 $164
2025 $114,598 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Incyte Corporation $302,489 240 payments
  2. Ortho Dermatologics, a division of Bausch Health US, LLC $90,439 104 payments
  3. AbbVie, Inc. $83,082 62 payments
  4. Arcutis Biotherapeutics, Inc. $64,438 10 payments
  5. Allergan Inc. $23,284 27 payments
  6. Merz North America, Inc. $12,810 1 payment
  7. Galderma Laboratories, L.P. $10,913 7 payments
  8. Pfizer Inc. $4,173 10 payments
  9. Aclaris Therapeutics, Inc. $2,956 4 payments
  10. Bausch & Lomb Americas Inc. $2,800 1 payment
  11. Other $11,853 41 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $293,280 52 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $231,263 66 payments
  3. Travel and Lodging $49,120 189 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $19,450 7 payments
  5. Food and Beverage $9,226 189 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $6,850 3 payments
  7. Education $50 1 payment
Products named General payments · program years 2019–2025
  1. OPZELURA $211,975 214 payments
  2. Zoryve $63,294 8 payments
  3. ARAZLO $33,456 30 payments
  4. ALTRENO $27,290 46 payments
  5. BOTOX $19,037 18 payments
  6. Cabtreo Dermatology $15,717 20 payments
  7. DUOBRII $13,709 17 payments
  8. Xeomin $12,810 1 payment
  9. SILIQ $7,995 13 payments
  10. Cabtreo Dermatology $6,870 10 payments
  11. Other $29,627 63 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Allergan Inc. $40,928 11 payments
  2. Eli Lilly and Company $1,861 1 payment
  3. AbbVie, Inc. $1,331 4 payments

Records

523 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record